Process Industries · Agricultural Commodities/Milling · NSE: INDOUS · data 2026-10-09

Indo US Bio-Tech Ltd.

Health check: Average (5.8/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹73.96

Market cap

₹146 cr

P/E

12.9

P/B

—

ROE

15.3%

ROCE

18.8%

Debt / equity

0.4

Dividend yield

0.00%

1-year return

-45.6%

52-week high

₹159

52-week low

₹70

Operating margin

12.9%

Growth

Revenue (last 12 months)	₹113 cr
Net profit (last 12 months)	₹11 cr
Sales growth, 3 years (yearly)	21.4%
Profit growth, 3 years (yearly)	21.9%

Similar companies

Dhunseri Tea & Industries Ltd (DTIL) · Dollex Agrotech Limited (DOLLEX) · Mangalam Seeds Ltd (MSL) · M K Proteins Limited (MKPL) · TBI Corn Limited (TBI)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open INDOUS in NSE Scanner →